Preference of Protein Intake and FTO rs1558902 Gene Polymorphism Among Women Obese
Department of Nutrition Science, Medical Faculty, Universitas Diponegoro Semarang, Indonesia
1 other identifier
observational
130
1 country
1
Brief Summary
The concept personalized gene-based nutrition combines genetic information with specific dietary intake that is crucial in managing obesity. Obesity experienced by adult women is generally caused by inapproriate diet and sedentary lifestyle. Variations in the fat mass and obesity-related gene (FTO) has been linked with susceptibility to obesity, but diet seems to change the relationship. A single nucleotide polymorphism (SNP) in the fat mass and obesity-associated gene (FTO) is a potent predictor of human obesity. Higher protein diets were more appropriate than standard protein diets, and frequently recommended as a weight loss plan as it prevents the loss of lean tissue mass. Nevertheless, high intakes of proteins may adversely affect metabolic functions. Multi studies have explored associated FTO polymorphisms with obesity in different populations. However, the contribution of the FTO common variants to obesity is controversial in Asian people, some studies showed rs1558902 was statistically associated with BMI, but other results reported FTO gene is not statistically associated with obesity. Given the diversity of Asian populations, the investigators generated a hypothesis whether relations between preference protein intake and FTO rs1558902 gene polymorphism exist in selected Indonesian obesity women
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2020
CompletedFirst Submitted
Initial submission to the registry
February 1, 2021
CompletedFirst Posted
Study publicly available on registry
February 5, 2021
CompletedMarch 2, 2021
February 1, 2021
2 months
February 1, 2021
February 25, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
fto gene rs 1558902
Genomic DNA was extracted from 300 ml of buffy coat using spin colomn method. rs 1558902 were genotyped using TaqMan probes C\_\_30090620\_10
day 1
interleukin-6
plasma IL-6 was determined by enzyme-linked immunosorbent method (EliKine™ Human IL-6 ELISA Kit)
day 1
Interventions
Blood samples were collected after a 12-h fasting by Prodia Laboratory for DNA isolation and biochemical analysis
Eligibility Criteria
healthy woman obese and pre menopause
You may qualify if:
- Body Mass index \> 25 kg/m2
- waist circumference \> 80 cm
You may not qualify if:
- chronic disease
- have pregnancy
- consume diet supplement, drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Etika Ratna Noer
Semarang, Central Java, 50275, Indonesia
Biospecimen
whole blood specimen intravenous 5ml
Study Officials
- PRINCIPAL INVESTIGATOR
Etika Noer, PhD
Diponegoro University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of Nutrition, Medical Faculty
Study Record Dates
First Submitted
February 1, 2021
First Posted
February 5, 2021
Study Start
August 1, 2020
Primary Completion
October 1, 2020
Study Completion
November 30, 2020
Last Updated
March 2, 2021
Record last verified: 2021-02